Scientists have announced new discoveries about the role of TET2 gene deficiency in the development of acute myeloid leukaemia (AML).
Up to 20% of AML cases have deficiency of or mutations in the TET2 gene. This speeds up the development of leukae...
8 months ago
A new drug in development for metabolic diseases could also benefit people with chronic myeloid leukaemia (CML).
Researchers found that targeting CML cells with MSDC-0160, a drug being tested for type 2 diabetes and Alzheimer’s disease, weakened t...
8 months ago
